BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32714888)

  • 21. Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts.
    Kim J; Lee M; Kim SY; Kim JH; Nam JS; Chun SW; Park SE; Kim KJ; Lee YH; Nam JY; Kang ES
    Endocrinol Metab (Seoul); 2021 Aug; 36(4):823-834. PubMed ID: 34474517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study.
    Yadav D; Choi E; Ahn SV; Koh SB; Sung KC; Kim JY; Huh JH
    Medicine (Baltimore); 2016 Aug; 95(31):e4447. PubMed ID: 27495073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SFI, a sex hormone binding globulin based nomogram for predicting non-alcoholic fatty liver disease in the Chinese population.
    Hua X; Zhang H; Yang W; Liu G; Zhang S; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1176019. PubMed ID: 37334312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
    Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
    World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels.
    Zhu W; Shi P; Fu J; Liang A; Zheng T; Wu X; Yuan S
    Lipids Health Dis; 2022 Dec; 21(1):149. PubMed ID: 36585668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of screening scores of non-alcoholic fatty liver disease in middle-aged and elderly Chinese.
    Liang Y; Ye M; Hou X; Chen P; Wei L; Jiang F; Feng L; Zhong L; Liu H; Bao Y; Jia W
    Diabetes Res Clin Pract; 2020 Nov; 169():108385. PubMed ID: 32853691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of hypertriglyceridemic waist phenotype with non-alcoholic fatty liver disease: a cross-sectional study in a Chinese population.
    Xuan Y; Gao P; Shen Y; Wang S; Gu X; Tang D; Wang X; Zhu F; Lu L; Chen L
    Hormones (Athens); 2022 Sep; 21(3):437-446. PubMed ID: 35597838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease.
    Peng H; Zhang J; Huang X; Xu M; Huang J; Wu Y; Peng XE
    Lipids Health Dis; 2023 Mar; 22(1):44. PubMed ID: 36991386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: An observational study.
    Yu XL; Shu L; Shen XM; Zhang XY; Zheng PF
    Medicine (Baltimore); 2017 Sep; 96(39):e8164. PubMed ID: 28953666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simpler diagnostic formula for screening nonalcoholic fatty liver disease.
    Feng G; He N; Zhou YF; Li XP; Niu C; Liu ML; Zhang KL; Li Y; Li YM; Zheng MH; Mi M
    Clin Biochem; 2019 Feb; 64():18-23. PubMed ID: 30503530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study.
    Zhu J; He M; Zhang Y; Li T; Liu Y; Xu Z; Chen W
    Endocr J; 2018 Mar; 65(3):373-381. PubMed ID: 29434074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting.
    Abd El-Wahab EW; Zein El-Abedin RA; Ahmed WM; Shatat HZ
    Am J Med Sci; 2020 Dec; 360(6):662-677. PubMed ID: 32739036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-lab and semi-lab algorithms for screening undiagnosed diabetes: A cross-sectional study.
    Li W; Xie B; Qiu S; Huang X; Chen J; Wang X; Li H; Chen Q; Wang Q; Tu P; Zhang L; Yan S; Li K; Maimaitiming J; Nian X; Liang M; Wen Y; Liu J; Wang M; Zhang Y; Ma L; Wu H; Wang X; Wang X; Liu J; Cai M; Wang Z; Guo L; Chen F; Wang B; Monica S; Carlsson PO; Sun Z
    EBioMedicine; 2018 Sep; 35():307-316. PubMed ID: 30115607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China.
    Lin S; Xian Y; Liu Y; Cai W; Song J; Zhang X
    Medicine (Baltimore); 2018 Mar; 97(9):e0021. PubMed ID: 29489647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.
    Chen LW; Huang PR; Chien CH; Lin CL; Chien RN
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):173-181. PubMed ID: 30981560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
    Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
    Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.